N. Keller

Efficacy and safety of a factor VIII–von Willebrand factor concentrate 8Y: stability, bacteriological safety, pharmacokinetic analysis and clinical experience

G. Kenet, A. Lubetsky, J. Luboshitz, 2002, Haemophilia : the official journal of the World Federation of Hemophilia.

Genotype/Phenotype Interactions and First Steps Toward Targeted Therapy for Sphingosine Phosphate Lyase Insufficiency Syndrome

J. Saba, Jen-Yeu Wang, N. Keller, 2021, Cell Biochemistry and Biophysics.

Tixagevimab-cilgavimab as an Early Treatment for COVID-19 in Kidney Transplant Recipients

L. Braun-Parvez, S. Fafi-Kremer, B. Moulin, 2022, medRxiv.

Efficacy of AAV9-mediated SGPL1 gene transfer in a mouse model of S1P lyase insufficiency syndrome

J. Hodgin, Jinghui Luo, B. Oskouian, 2021, JCI insight.